Effect of sunitinib in a patient with primary imatinib-resistant gastrointestinal stromal tumor.

被引：0
|
作者：
Xue, Zhigang
Ma, Zhiqiang
Kang, Weiming
Yu, Jianchun
机构：
[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing, Peoples R China
[2] Peking Union Med Coll Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e23516
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23516
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Ripretinib for the treatment of advanced, imatinib-resistant gastrointestinal stromal tumors
    Liu, Wei Zhen
    Du, Yu Qiang
    Shen, Qian
    Tao, Kai Xiong
    Zhang, Peng
    JOURNAL OF DIGESTIVE DISEASES, 2023,
  • [22] Identification of Novel Imatinib-Resistant Genes in Gastrointestinal Stromal Tumors
    Cao, Lei
    Zheng, Kunming
    Liu, Yanhong
    Song, Peng
    Wang, Chuntao
    Wang, Hongzhi
    Wang, Nan
    Zhang, Shiwu
    Zhao, Yongjie
    FRONTIERS IN GENETICS, 2022, 13
  • [23] Current clinical strategy for imatinib-resistant gastrointestinal stromal tumors
    Yamamoto M.
    Konno H.
    Clinical Journal of Gastroenterology, 2009, 2 (3) : 137 - 142
  • [24] Novel Insights into the Treatment of Imatinib-Resistant Gastrointestinal Stromal Tumors
    Serrano, Cesar
    George, Suzanne
    Valverde, Claudia
    Olivares, David
    Garcia-Valverde, Alfonso
    Suarez, Cristina
    Morales-Barrera, Rafael
    Carles, Joan
    TARGETED ONCOLOGY, 2017, 12 (03) : 277 - 288
  • [25] Novel Insights into the Treatment of Imatinib-Resistant Gastrointestinal Stromal Tumors
    César Serrano
    Suzanne George
    Claudia Valverde
    David Olivares
    Alfonso García-Valverde
    Cristina Suárez
    Rafael Morales-Barrera
    Joan Carles
    Targeted Oncology, 2017, 12 : 277 - 288
  • [26] Novel approaches to gastrointestinal stromal tumors resistant to imatinib and sunitinib
    Cassier P.A.
    Dufresne A.
    Arifi S.
    Sayadi H.
    Ray-Coquard I.
    Bringuier P.-P.
    Scoazec J.-Y.
    Alberti L.
    Blay J.-Y.
    Current Gastroenterology Reports, 2008, 10 (6) : 555 - 561
  • [27] Antitumor Effect of the Tyrosine Kinase Inhibitor Nilotinib on Gastrointestinal Stromal Tumor (GIST) and Imatinib-Resistant GIST Cells
    Sako, Hiroyuki
    Fukuda, Kazumasa
    Saikawa, Yoshiro
    Nakamura, Rieko
    Takahashi, Tsunehiro
    Wada, Norihito
    Kawakubo, Hirohumi
    Takeuchi, Hiroya
    Ohmori, Tai
    Kitagawa, Yuko
    PLOS ONE, 2014, 9 (09):
  • [28] Sorafenib inhibits the imatinib-resistant KITT6701 gatekeeper mutation in gastrointestinal stromal tumor
    Guo, Tianhua
    Agaram, Narasimhan P.
    Wong, Grace C.
    Hom, Glory
    D'Adamo, David
    Maki, Robert G.
    Schwartz, Gary K.
    Veach, Darren
    Clarkson, Bayard D.
    Singer, Samuel
    DeMatteo, Ronald P.
    Besmer, Peter
    Antonescu, Cristina R.
    CLINICAL CANCER RESEARCH, 2007, 13 (16) : 4874 - 4881
  • [29] Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor
    Sakurama, Kazufumi
    Noma, Kazuhiro
    Takaoka, Munenori
    Tomono, Yasuko
    Watanabe, Nobuyuki
    Hatakeyama, Shinji
    Ohmori, Osamu
    Hirota, Seiichi
    Motoki, Takayuki
    Shirakawa, Yasuhiro
    Yamatsuji, Tomoki
    Haisa, Minoru
    Matsuoka, Junji
    Tanaka, Noriaki
    Naomoto, Yoshio
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (01) : 127 - 134
  • [30] Establishment and characterization of imatinib-resistant xenograft models of human gastrointestinal stromal tumor in mice.
    Zheng, Song
    Huang, Ke-er
    Zhou, Yao
    Tao, De-you
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345